Takeda Pharmaceutical Company Limited (TAK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 14.12 |
| Open | 14.14 |
| Bid | 13.60 x 1800 |
| Ask | 0.00 x 2900 |
| Day's range | 14.14 - 14.27 |
| 52-week range | 13.05 - 17.31 |
| Volume | |
| Avg. volume | 2,616,216 |
| Market cap | 44.341B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 30.32 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.80 (5.64%) |
| Ex-dividend date | 29 Sept 2021 |
| 1y target est | N/A |
- Zacks
TAK vs. ZTS: Which Stock Should Value Investors Buy Now?
TAK vs. ZTS: Which Stock Is the Better Value Option?
- Zacks
Wall Street Analysts See a 26% Upside in Takeda Pharmaceutical Co. (TAK): Can the Stock Really Move This High?
The consensus price target hints at a 26.4% upside potential for Takeda Pharmaceutical Co. (TAK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Motley Fool
What's Winning in 2022? 3 Stocks That Are Doing Fine
It's been an ugly year in the stock market in 2022, and most investors are deep in the red. For instance, Immunocore (NASDAQ: IMCR) investors just had a U.S. Food and Drug Administration (FDA) approval, and that stock has shot higher with a 30% gain this year. Will Axsome Therapeutics (NASDAQ: AXSM) be the next stock to pop?
© 2022 Yahoo. All rights reserved.
